leisure time -WSS

leisure time

author：comprehensive 2025-09-27 19:37:34 - browse：26558

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： STAT Virtual Event: JPM Recap, Live!

focus

WSS

Cosmetics set for new safety regulation. Why the industry is on board

Startup Neumora takes a novel depression drug to Phase 3

A public scorecard can help hold safety

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

JPM pitch from hospitals? Revenue streams outside of patient care

Medicare Advantage overpayments discussion gets experts fired up

entertainment

leisure time

leisure time

At least 13 dead in Texas as scorching temps continue

At JPM 2024, hospital systems pitch financial strength to investors

Trump demands the U.S. pay no more for drugs than other countries … again

Allen Institute goes after foundational questions, CEO Costa says

Continuity nursing helped my family in our darkest PICU moments

Whistleblower: Blue Cross Blue Shield evaded $170 million in taxes

Wildfire smoke exposes gaps in outdoor worker protections

American taxpayers paid $1.8 trillion in health care costs in 2022

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

As digital health tech proliferates, a new institute aims to cut through hype

knowledge

Listen: Wegovy in the brain & pivotal Alzheimer's data

WHO calls for emergency meeting on new China virus, as cases spread

Profiling embryos to choose those with higher IQs is almost a reality

Google and Epic fight stronger regulation of AI in health care

How Medicaid coverage policies for immigrants impact new moms

JPM 2024 Review: Hope for the XBI, deals from J&J, Merck, GSK

Wikipedia

focus

focus

explore